← Back to Clinical Trials
Recruiting NCT07447362

NCT07447362 Clinical Management of Cardiovascular Risk Factors in Adult Patients: A Before-and-After Interventional Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07447362
Status Recruiting
Phase —
Sponsor Universidad Católica San Antonio de Murcia
Condition Cardiovascular Risk Factors
Study Type INTERVENTIONAL
Enrollment 220 participants
Start Date 2024-07-24
Primary Completion 2026-07-24

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Structured Cardiovascular Risk Management

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 220 participants in total. It began in 2024-07-24 with a primary completion date of 2026-07-24.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate cardiovascular risk factors, clinical characteristics, and outcomes in adult patients attending an outpatient cardiology clinic. The research focuses on identifying predictors of adverse cardiovascular events, optimizing risk stratification, and improving preventive strategies in routine clinical practice. Data will be collected from patients receiving standard cardiology care without altering their treatment. The results are expected to contribute to better understanding of cardiovascular risk profiles and to support improvements in clinical decision-making and patient management.

Eligibility Criteria

Inclusion Criteria: * Age ≥18 years * Presence of at least one cardiovascular risk factor (hypertension, diabetes, dyslipidemia, obesity, or smoking) * Receiving outpatient clinical follow-up * Ability to provide informed consent Exclusion Criteria: * Severe clinical instability requiring hospitalization * Pregnancy * End-stage renal disease or dialysis * Inability to complete follow-up visits * Refusal to participate

Contact & Investigator

Central Contact

Julio César Núñez Farías, MD, MSc (Cardiology)

✉ llaillai@yahoo.es

📞 +56965860130

Principal Investigator

José Abellán Alemán, MD, PhD

STUDY CHAIR

Universidad Católica San Antonio de Murcia

Frequently Asked Questions

Who can join the NCT07447362 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Risk Factors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07447362 currently recruiting?

Yes, NCT07447362 is actively recruiting participants. Contact the research team at llaillai@yahoo.es for enrollment information.

Where is the NCT07447362 trial being conducted?

This trial is being conducted at Santiago, Chile.

Who is sponsoring the NCT07447362 clinical trial?

NCT07447362 is sponsored by Universidad Católica San Antonio de Murcia. The principal investigator is José Abellán Alemán, MD, PhD at Universidad Católica San Antonio de Murcia. The trial plans to enroll 220 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology